Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowThis statistic shows the EBITDA of Fresenius SE from 2019 to 2023. In 2019, the German medical technology company totaled around 3.2 billion euros of EBITDA worldwide, by 2023 the company's EBITDA had increased to over 3.4 billion euros.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Market position
Key facts
Business distribution
Competitors
Further related statistics
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.